欧州アレルギー・臨床免疫学会2024 (EAACI Congress 2024)：アレルギー治療の革新と進歩
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
学会中は、環境科学の進歩、食物アレルギー、免疫療法の革新、小児アレルギーなどに焦点を当てた、150を超える科学セッションが開催される。精密医療、AI、免疫療法、免疫調節剤が、最大規模のアレルギーおよび免疫学学会に集結。同学会は、5月31日から6月3日までスペインのバレンシアで開催される。 スペイン、バレンシア発, April 30, 2024 (GLOBE NEWSWIRE) --...
Kongres EAACI 2024: Inovasi dan Kemajuan dalam Pengobatan Alergi
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Lebih dari 150 sesi ilmiah akan dipresentasikan selama pelaksanaan kongres, dengan fokus di berbagai bidang yang di antaranya mencakup kemajuan dalam sains lingkungan, alergi makanan, inovasi...
Congrès EAACI 2024 : innovations et progrès dans le traitement des allergies
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Lors de ce congrès, plus de 150 sessions scientifiques seront présentées. Les sujets abordés se concentreront sur les progrès de la science environnementale, les allergies alimentaires, les...
2024 年欧洲过敏与临床免疫学会大会：过敏治疗的创新和进步
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
大会期间将举行 150 多场科学会议，重点探讨环境科学、食物过敏、免疫疗法创新和儿科过敏等方面的进展。作为规模最大的过敏和免疫学盛会，本次大会将汇聚精准医学、人工智能、免疫疗法和免疫调节剂等前沿领域。大会将于 5 月 31 日至 6 月 3 日在西班牙巴伦西亚举行。 巴伦西亚，西班牙, April 30, 2024 (GLOBE NEWSWIRE) -- 由来自 125 个国家的...
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
April 25, 2024 07:00 ET
|
Purple Biotech Ltd.
Interim data suggests reduced risk of progression or death in the CM24/nivolumab plus standard of care Nal-IRI/5FU/LV arm of the study REHOVOT, Israel, April 25, 2024 (GLOBE NEWSWIRE) --...
International Surrealism Now Exhibition Set to Open in Portugal
February 06, 2024 10:00 ET
|
International Surrealism
Mafra, Portugal, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The much-anticipated "International Surrealism Now" exhibition is set to open its doors from February 5th to 17th, 2024, at the historic Palácio de...
Holaluz cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023
January 31, 2024 03:52 ET
|
Holaluz Clidom SA
Barcelona, 31 de enero de 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023 Holaluz duplica su cuota de mercado...
Holaluz delivers on Normalised EBITDA guidance, reaching 3M€ for FY2023
January 31, 2024 03:52 ET
|
Holaluz Clidom SA
Barcelona, January 31, 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) delivers on Normalised EBITDA guidance, reaching 3M€ for FY2023 Holaluz doubled its solar market share in 2023...
Germany tops the list for Dutch Travellers most visited country
November 22, 2023 01:24 ET
|
Arriving In High Heels Corporation
The Travel App, Visited releases top 10 countries most visited by Dutch travellers. The list includes: Germany, Belgium, France to name a few.
Statkraft acquires Spanish based renewables business Enerfin from Elecnor Group
November 17, 2023 16:00 ET
|
Statkraft AS
Milestone acquisition for Statkraft, Europe’s largest generator of renewable energy (Oslo/Madrid) The acquisition of Enerfin adds 1.5 GW of operational wind power, wind and solar capacity...